Clinical Trial Update: Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers [Phase 1, Phase 2]

View source ↗

Summary

This entry reports the completion and results posting of a Phase 1/2 study evaluating Sanofi Pasteur's live-attenuated respiratory syncytial virus vaccine in in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Live-attenuated Respiratory Syncytial Virus Vaccine (live-attenuated RSV vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Respiratory Syncytial Virus Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-06-13